- Novel small molecule-derived, highly selective substrates for fibroblast activation protein (FAP)(2019)
Auteurs: An De Decker, Gwendolyn Vliegen, Dries Van Rompaey, Anke Peeraer, An Bracke, Line Verckist, Koen Jansen, Ruth Geiss-Friedlander, Koen Augustyns, Hans De Winter, et al.
Pagina's: 1173 - 1179
- Efforts towards an on‐target version of the Groebke‐Blackburn‐Bienaymé (GBB) reaction for discovery of druglike urokinase (uPA) inhibitors(2019)
Auteurs: Rafaela Gladysz, Johannes Vrijdag, Dries Van Rompaey, Anne-Marie Lambeir, Koen Augustyns, Hans De Winter, Pieter Van Der Veken
Pagina's: 12380 - 12393
- Tozasertib analogues as inhibitors of necroptotic cell death(2018)
Auteurs: Sam Hofmans, Lars Devisscher, Sofie Martens, Dries Van Rompaey, Kenneth Goossens, Tatyana Divert, Wim Nerinckx, Nozomi Takahashi, Hans De Winter, Pieter Van Der Veken, et al.
Pagina's: 1895 - 1920
- Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy(2018)
Auteurs: Lars Devisscher, Samaya Van Coillie, Sam Hofmans, Dries Van Rompaey, Kenneth Goossens, Eline Meul, Hans De Winter, Pieter Van Der Veken, Peter Vandenabeele, Tom Vanden Berghe, et al.
Pagina's: 10126 - 10140
- TSLP(2018)
Auteurs: Dries Van Rompaey
Aantal pagina's: 171
- Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma(2017)
Auteurs: Kenneth Verstraete, Frank Peelman, Harald Braun, Dries Van Rompaey, Hans De Winter, Juan Lopez, Ann Dansercoer, Isabel Vandenberghe, Kris Pauwels, Jan Tavernier, et al.
- Virtual screening for inhibitors of the human TSLP:TSLPR interaction(2017)
Auteurs: Dries Van Rompaey, Kenneth Verstraete, Frank Peelman, Savvas N. Savvides, Koen Augustyns, Pieter Van Der Veken, Hans De Winter